@sponlinecoaching's self-administered TRT claims, fact-checked

What did @sponlinecoaching actually say?

The creator walked through how to self-inject testosterone, directing viewers to inject "subcutaneously" into fat tissue around the love handles or glutes rather than into muscle. He acknowledged starting TRT "without the help of a clinic," said he "wouldn't advise" that approach, then offered paid coaching via DMs for anyone who has already done the same. His core technical claim is that subcutaneous injection is "the preferable way" at doses around 100 milligrams per week.

That framing matters. He is not presenting this as a clinical recommendation. He is presenting himself as a self-taught practitioner offering personal experience as a substitute for medical oversight, then monetizing that audience through private coaching. That context shapes how everything else should be read.

Does the science back this up?

On the narrow question of subcutaneous versus intramuscular injection for testosterone, the evidence is actually reasonably supportive of what he is saying, though not quite as clean as he implies.

A 2017 study by Spratt et al. in the Journal of the Endocrine Society found that subcutaneous testosterone cypionate produced stable serum testosterone levels comparable to intramuscular delivery, with lower peak-to-trough variability. Lower variability is genuinely considered a clinical advantage because large swings in testosterone levels correlate with mood instability and erythrocytosis risk. A 2021 review by Ramasamy et al. in Therapeutic Advances in Urology similarly noted that subcutaneous delivery is gaining acceptance in clinical practice, particularly at weekly or twice-weekly low-volume dosing.

The love handles and abdominal fat as injection sites are also consistent with standard subcutaneous technique taught in clinical settings. None of this is fabricated. The problem is not what he said about injection method. The problem is the larger framework he built around it.

What did they get wrong (or right)?

He got the subcutaneous technique directionally right. Credit where it is due: the claim that subcutaneous is preferable at lower weekly doses has real clinical backing. The 100 mg per week figure he cites is within a commonly used clinical range, though describing any specific dose number in public content aimed at unsupervised users is a problem in itself.

What he got wrong is more consequential. Saying "I wouldn't advise" starting TRT without a clinic, then immediately offering to coach people who already have, is not a safety disclaimer. It is a sales pitch with a liability hedge attached. Unmonitored TRT carries real risks: erythrocytosis (elevated hematocrit), suppression of the hypothalamic-pituitary-gonadal axis, infertility, and cardiovascular strain. A 2023 paper by Lincoff et al. in the New England Journal of Medicine found that testosterone therapy in middle-aged men was associated with increased rates of pulmonary embolism and atrial fibrillation in a large cardiovascular outcomes trial. None of that appears here.

There is also no mention of needle gauge, injection volume limits for subcutaneous tissue, or how to recognize injection site reactions. For a video framed as a how-to guide, those omissions are not minor.

What should you actually know?

If you are considering TRT, the injection method is genuinely one of the smaller decisions you will make. The bigger ones involve bloodwork. Before starting testosterone, a clinician should assess total testosterone, free testosterone, LH, FSH, estradiol, hematocrit, and PSA at minimum. These are not bureaucratic checkboxes. They establish whether low testosterone is actually the problem, whether the cause is primary or secondary hypogonadism, and whether TRT is safe for you specifically.

Subcutaneous injection, as the creator describes it, is a legitimate and increasingly preferred delivery method in supervised clinical settings. The Endocrine Society's clinical practice guidelines do recognize it as an option. But the technique being valid does not make self-administration without monitoring valid.

• Hematocrit should be monitored every 3 to 6 months on TRT. Elevated hematocrit increases clot risk.
• Testosterone suppresses natural production. Coming off without proper guidance can leave you with prolonged hypogonadism.
• Injection site infections, though uncommon, are a real complication of any injectable therapy done without proper sterile technique training.

A regulated telehealth platform can prescribe, monitor, and adjust your protocol based on actual lab values. That is not the same thing as DM coaching from someone who started their own TRT without medical supervision and is now teaching others to do the same.